Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction

Area of Science:

• Immunology
• Medicinal Chemistry
• Drug Discovery

Background:

• Costimulatory interactions are crucial for T cell activation and immune responses.
• Targeting protein-protein interactions, like CD40-CD40L, with small molecules presents a significant challenge in drug development.

Purpose of the Study:

• To identify novel small-molecule inhibitors targeting the CD40-CD40L costimulatory pathway.
• To demonstrate the feasibility of small-molecule inhibition for protein-protein interactions involved in immune responses.

Main Methods:

• Drug design based on the chemical space of organic dyes.
• In vitro cell-based assays to evaluate compound activity, including NF-κB sensor cells, THP-1 myeloid cells, and primary human B cells.
• In vivo studies using murine models for allogeneic skin transplantation and T cell expansion.

Main Results:

• Identification of potent small-molecule inhibitors, such as DRI-C21045, with low micromolar IC50 values.
• Demonstrated inhibition of CD40L-induced activation in various cell types and reduced T cell expansion in vivo.
• Confirmed specificity against other TNF-superfamily interactions and lack of cytotoxicity at effective concentrations.

Conclusions:

• Novel small molecules derived from organic dyes can effectively inhibit CD40-CD40L interactions.
• These findings provide proof-of-principle for targeting costimulatory protein-protein interactions with small molecules.
• The identified compounds and structural insights can guide the development of new immunotherapeutic agents.